Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease

Glycosylation is a cell type-specific post-translational modification that can be used for biomarker identification in various diseases. Aim of this study is to explore glycan-biomarkers on transferrin (Tf) for Alzheimer’s disease (AD) in cerebrospinal fluid (CSF). Glycan structures of CSF Tf were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshi, Kyoka, Ito, Hiromi, Abe, Eriko, Fuwa, Takashi J., Kanno, Mayumi, Murakami, Yuta, Abe, Mitsunari, Murakami, Takenobu, Yoshihara, Akioh, Ugawa, Yoshikazu, Saito, Takashi, Saido, Takaomi C., Matsumoto, Kana, Yamaguchi, Yoshiki, Furukawa, Katsutoshi, Arai, Hiroyuki, Kanai, Mitsuyasu, Miyajima, Masakazu, Arai, Hajime, Ogawa, Norihiro, Akatsu, Hiroyasu, Hashizume, Yoshio, Tateno, Hiroaki, Honda, Takashi, Hashimoto, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470343/
https://www.ncbi.nlm.nih.gov/pubmed/34564432
http://dx.doi.org/10.3390/metabo11090616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470343/
https://www.ncbi.nlm.nih.gov/pubmed/34564432
http://dx.doi.org/10.3390/metabo11090616

Ejemplares similares